Colgate Palmolive (CL)

Currency in USD
85.81
+1.08(+1.27%)
Closed·
85.57-0.24(-0.28%)
·
Earnings results expected in 7 days
CL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
84.5085.95
52 wk Range
74.55100.18
Key Statistics
Prev. Close
85.81
Open
84.84
Day's Range
84.5-85.95
52 wk Range
74.55-100.18
Volume
9.16M
Average Volume (3m)
6.82M
1-Year Change
-2.3888%
Book Value / Share
1.06
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
88.79
Upside
+3.47%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom’s of Maine, EltaMD, Filorga, Irish Spring, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, and Soupline brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill’s Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill’s Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Colgate-Palmolive Company SWOT Analysis


Global Market Leade
Colgate-Palmolive's strong brand portfolio and successful 2025 strategy position it as a formidable player in the consumer goods secto
Navigating Challenges
Explore how the company addresses currency fluctuations, category slowdowns, and competitive pressures while maintaining impressive profit margins
Future-Focused Strategy
Delve into Colgate-Palmolive's 2030 strategy and three-year restructuring program aimed at unlocking growth potential and enhancing operational efficiency
Analyst Perspectives
Discover varied price targets ranging from $87 to $97, reflecting analysts' views on Colgate-Palmolive's growth prospects and market positioning
Read full SWOT analysis

Colgate-Palmolive Company Earnings Call Summary for Q2/2025

  • Colgate-Palmolive reported Q2 2025 net sales growth and accelerated organic sales of 2.4%, despite raw material inflation and FX impacts, with stock rising 1% in premarket trading.
  • Gross margin declined 420 basis points year-over-year due to raw material inflation, prompting the announcement of a $200-$300 million productivity initiative.
  • The company maintained its guidance for low single-digit EPS growth for 2025, expecting modest category improvements in the latter half of the year.
  • CEO Noel Wallace emphasized focus on value offerings, innovation, and artificial intelligence, stating 'AI will be a difference maker for us in our RGM efforts.'
  • Regional performance varied with North America focusing on margin restoration, Latin America accepting price increases, and Hill's Pet Nutrition showing strong performance.
Last Updated: 30/10/2025, 15:28
Read Full Transcript

Compare CL to Peers and Sector

Metrics to compare
CL
Peers
Sector
Relationship
P/E Ratio
23.8x27.2x12.1x
PEG Ratio
9.30−1.600.03
Price/Book
80.8x6.6x1.5x
Price / LTM Sales
3.4x2.5x0.9x
Upside (Analyst Target)
2.6%8.9%17.9%
Fair Value Upside
Unlock10.2%11.8%Unlock

Analyst Ratings

13 Buy
8 Hold
0 Sell
Ratings:
21 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 88.79
(+3.47% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
UBS
Buy93.00+8.38%93.00Maintain22/01/2026
Barclays
Hold83.00-3.27%80.00Maintain19/01/2026
JPMorgan
Buy93.00+8.38%88.00Maintain16/01/2026
UBS
Buy93.00+8.38%90.00Maintain14/01/2026
Wells Fargo
Hold86.00+0.22%77.00Upgrade13/01/2026

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3.57%
Dividend Yield
2.42%
Industry Median 2.72%
Annualised payout
2.08
Paid quarterly
5-Years Growth
+3.23%
Growth Streak

Earnings

Latest Release
Oct 31, 2025
EPS / Forecast
0.91 / 0.89
Revenue / Forecast
5.13B / 5.13B
EPS Revisions
Last 90 days

People Also Watch

365.83
GD
+0.29%
114.71
LEN
-2.79%
180.27
NUE
+0.02%
160.72
STZ
-1.63%
101.34
MDT
+1.05%

FAQ

What Is the Colgate-Palmolive (CL) Share Price Today?

The live Colgate-Palmolive share price today is 85.81

What Stock Exchange Does Colgate-Palmolive (CL) Trade On?

Colgate-Palmolive is listed and trades on the New York Stock Exchange.

What Is the Ticker (Stock Symbol) for Colgate-Palmolive?

The stock symbol (also called a 'ticker') for Colgate-Palmolive is "CL."

Does Colgate-Palmolive Pay Dividends? What’s The Current CL Dividend Yield?

Yes, CL Pays Dividends to its Shareholders. The current Colgate-Palmolive dividend yield is 2.42%.

What Is the Current Colgate-Palmolive Market Cap?

As of today, Colgate-Palmolive market capitalisation is 69.17B.

What Is Colgate-Palmolive's (CL) Earnings Per Share (TTM)?

The Colgate-Palmolive EPS is currently 3.57 (Trailing Twelve Months).

When Is the Next Colgate-Palmolive Earnings Date?

Colgate-Palmolive's next earnings report will be released on 30 Jan 2026.

Is CL a Buy or Sell From a Technical Analyst Perspective?

Based on today's Colgate-Palmolive moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Colgate-Palmolive Stock Split?

Colgate-Palmolive has split 5 times. (See the CL stock split history page for full effective split date and price information.)

How Many Employees Does Colgate-Palmolive Have?

Colgate-Palmolive has 34000 employees.

What is the current trading status of Colgate-Palmolive (CL)?

As of 23 Jan 2026, Colgate-Palmolive (CL) is trading at a price of 85.81, with a previous close of 85.81. The stock has fluctuated within a day range of 84.50 to 85.95, while its 52-week range spans from 74.55 to 100.18.

What Is Colgate-Palmolive (CL) Price Target According to Analysts?

The average 12-month price target for Colgate-Palmolive is USD88.79, with a high estimate of USD95 and a low estimate of USD81. 13 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +3.47% Upside potential.

What Is the CL Premarket Price?

CL's last pre-market stock price is 85.57. The pre-market share volume is 263.00, and the stock has decreased by -0.24, or -0.28%.

What Is the CL After Hours Price?

CL's last after hours stock price is 85.90, the stock has decreased by 0.09, or 0.10%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.